Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H GILBERT

Showing results (781-790 of 824) with videos related to

Pageof 83
Sort By:
ACS Infectious Diseases|September 15, 2021
Prioritization of Molecular Targets for Antimalarial Drug DiscoveryBarbara Forte, Sabine Ottilie, Andrew Plater, et al.
Journal of Medicinal Chemistry|December 14, 2011
Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitorsStephen Brand, Laura A T Cleghorn, Stuart P McElroy, et al.
Journal of Medicinal Chemistry|June 21, 2023
Development of a 2,4-Diaminothiazole Series for the Treatment of Human African Trypanosomiasis Highlights the Importance of Static-Cidal Screening of AnaloguesLaura A T Cleghorn, Richard J Wall, Sébastien Albrecht, et al.
JCI Insight|March 30, 2017
TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birthDavid J Dowling, Simon D van Haren, Annette Scheid, et al.
European Journal of Medicinal Chemistry|May 20, 2022
Identification and development of a series of disubstituted piperazines for the treatment of Chagas diseaseKate McGonagle, Gary J Tarver, Juan Cantizani, et al.
Nature|December 14, 2012
Automated design of ligands to polypharmacological profilesJérémy Besnard, Gian Filippo Ruda, Vincent Setola, et al.
Journal of Medicinal Chemistry|April 27, 2021
Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral LeishmaniasisMichael Thomas, Stephen Brand, Manu De Rycker, et al.
Journal of Medicinal Chemistry|November 21, 2014
Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasisStephen Brand, Neil R Norcross, Stephen Thompson, et al.
Journal of Dental Research|February 15, 2011
Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRNA Barasch, J Cunha-Cruz, F A Curro, et al.
Texas Dental Journal|June 18, 2013
Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR Dental PBRNA Barasch, J Cunha-Cruz, F A Curro, et al.
Pageof 83

Showing results (781-790 of 824) with videos related to

Sort By:
Pageof 83
ACS Infectious Diseases|September 15, 2021
Prioritization of Molecular Targets for Antimalarial Drug DiscoveryBarbara Forte, Sabine Ottilie, Andrew Plater, et al.
Journal of Medicinal Chemistry|December 14, 2011
Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitorsStephen Brand, Laura A T Cleghorn, Stuart P McElroy, et al.
Journal of Medicinal Chemistry|June 21, 2023
Development of a 2,4-Diaminothiazole Series for the Treatment of Human African Trypanosomiasis Highlights the Importance of Static-Cidal Screening of AnaloguesLaura A T Cleghorn, Richard J Wall, Sébastien Albrecht, et al.
JCI Insight|March 30, 2017
TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birthDavid J Dowling, Simon D van Haren, Annette Scheid, et al.
European Journal of Medicinal Chemistry|May 20, 2022
Identification and development of a series of disubstituted piperazines for the treatment of Chagas diseaseKate McGonagle, Gary J Tarver, Juan Cantizani, et al.
Nature|December 14, 2012
Automated design of ligands to polypharmacological profilesJérémy Besnard, Gian Filippo Ruda, Vincent Setola, et al.
Journal of Medicinal Chemistry|April 27, 2021
Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral LeishmaniasisMichael Thomas, Stephen Brand, Manu De Rycker, et al.
Journal of Medicinal Chemistry|November 21, 2014
Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasisStephen Brand, Neil R Norcross, Stephen Thompson, et al.
Journal of Dental Research|February 15, 2011
Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRNA Barasch, J Cunha-Cruz, F A Curro, et al.
Texas Dental Journal|June 18, 2013
Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR Dental PBRNA Barasch, J Cunha-Cruz, F A Curro, et al.
Pageof 83